USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
25-May-2005
North America
Market Research
F337-01-00-00-00
HC01446-NA-MR_05925
The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspectives of the market. A number of strategic recommendations to be successful are provided in the research service.
Executive Summary
- Executive Summary
Objectives and Scope
- Objectives
- Scope
Monoclonal Antibodies Market Overview
- Introduction
- Structure of Antibodies
- Typical Problems with Murine mAbs
- The Role of Hybridoma Clone
- Medical Utility of mAbs
- Market Overview
Evolution and Technology Trends
- Introduction
- Early Murine mAbs
- Chimeric mAbs
- Humanized mAbs
- Fully Human mAbs
- Phage Display of Human mAbs
- Monoclonal Antibodies as Carriers
- Naked Monoclonal Antibodies
- Conjugated Monoclonal Antibodies
Future of Monoclonal Antibodies
- The Foundation for Optimistic Future
- Return on Investment and Future
Challenges Affecting the US Therapeutic Monoclonal Antibodies Market
Overview of the mAbs Pipeline
Market Dynamics
Market Forecasts
Frost and Sullivan Awards
- Introduction
- Market Engineering Measurement
- Market Drivers
- Market Restraints
Competitive Structure
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Overview
Market Forecasts
Competitive Analysis
Strategic Recommendations
Oncology Databases
Autoimmune and Inflammatory Disorders Databases
Organ Transplant Databases
Cardiovascular Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
26 Aug 2026 | Global | Technology Research
Growth Opportunities and Advancements in Acute and Chronic Wound Care
A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...
26 Aug 2026 | Global | Frost Radar
Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026
Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F337-01-00-00-00 |
| Is Prebook | No |
U.S. Therapeutic Monoclonal Antibodies Markets
$2,450.00
Special Price $1,837.50 save 25 %